{"ticker": {"uuid": "d51609e8-244c-4ceb-9401-1366d81e2345", "symbol": "SERA", "name": "Sera Prognostics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "abrdn Group holds 7.21% of Sera Prognostics (SERA) stock", "summary": "abrdn Group plc and its subsidiary abrdn Inc. have reported a beneficial ownership of 7.21% in Sera Prognostics, Inc.'s Class A common stock, totaling 2,753,525 shares as of June 30, 2026. Both entities share voting and dispositive power over these shares, which are held on behal", "url": "https://www.stocktitan.net/sec-filings/SERA/schedule-13g-a-sera-prognostics-inc-amended-passive-investment-disclo-0d3c957b2049.html", "source_name": "Stock Titan", "published_at": "2026-07-15T14:44:35", "published_display": "15 Jul 2026 14:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics grants RSUs and options to director | SERA Insider Trading", "summary": "Sera Prognostics (SERA) director Joshua Phillips received equity compensation awards on July 10, 2026, as detailed in a Form 4 filing. These awards include RSUs for 2,260 and 22,426 Class A shares and stock options for 3,477 and 34,494 shares with an exercise price of $1.97. The ", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-4488bf237da4.html", "source_name": "Stock Titan", "published_at": "2026-07-15T00:12:52", "published_display": "15 Jul 2026 00:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics (SERA) awards RSUs and $1.97 stock options to director", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNdnBpTGY3Y1dmc1BxTG4yV3dCQTRzNFRNT1drTF9DaWdZdnN5aUN3Vnp5ZnhYMG94Z0JuV3B4OF9Sczl1NllWRDM0c2RqV3ZBNmltdG1FRTExcFFLYTh6LVlBQmhOSjF4XzJCbUh5cWlRTy1WSElMb3pxbDBSR204emMtSi1tTk0yRmIwUC1xOHI4SUpfTS1EbUo1R2RFS2NFZDlkYjliS0lPb0hoMldDa09DdDM?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T22:41:44+00:00", "published_display": "14 Jul 2026 22:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics (SERA) grants new RSUs and stock options", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNUXg3a09ZY3RmeTRTUklEMWZ0dGhrMW9WZnNzak05VW9pYktnUW9WZkFMV0dHR1liM2xyMDdqTDhIY2lYRDJ4Rk1OaFZYcFZacDVtV3dCMVg0cjZBdEVCQ0ZGSkp3M0E3MDFCd2EyLTlZSlhwYUN6VW5SaVIwTFBNQnc4VWpmYl85d3pWejNrRnRSTkI2QjZURHdaaTl5RHVrSWtyNXpxV0tRUEhFT1lGT3BfTkc?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T22:41:21+00:00", "published_display": "14 Jul 2026 22:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Equity grants: Sera Prognostics (SERA) awards RSUs and options", "summary": "Sera Prognostics (SERA) board director Sandra AJ Lawrence recently received equity awards including Restricted Stock Units (RSUs) and stock options. These awards were part of her compensation, with the RSUs and options vesting based on continued service and specific dates or the ", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-e8fabd3b69c8.html", "source_name": "Stock Titan", "published_at": "2026-07-14T23:12:52", "published_display": "14 Jul 2026 23:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics (SERA) director receives RSU and stock option grants", "summary": "Sera Prognostics, Inc. director Mirza Mansoor Raza received equity awards on July 10, 2026, including Restricted Stock Units (RSUs) for 1,771 and 22,426 shares of Class A common stock, and stock options for 2,725 and 34,494 shares at an exercise price of $1.97. These awards are p", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-eb90f99076fe.html", "source_name": "Stock Titan", "published_at": "2026-07-14T23:12:52", "published_display": "14 Jul 2026 23:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics (SERA) grants RSUs and stock options to director Kim Kamdar", "summary": "Sera Prognostics (SERA) Director Kim P. Kamdar received equity compensation on July 10, 2026, including Restricted Stock Units (RSUs) and stock options. Kamdar was granted 3,421 and 22,426 RSU-linked shares of Class A Common Stock, which vest on the earlier of July 10, 2027, or t", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-e049fad5d6aa.html", "source_name": "Stock Titan", "published_at": "2026-07-14T22:12:52", "published_display": "14 Jul 2026 22:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics (SERA) grants RSUs and options to director", "summary": "Sera Prognostics director Gregory C. Critchfield received new equity awards on July 10, 2026, including restricted stock units (RSUs) and stock options. The RSUs comprise 1594 and 22426 Class A shares, vesting on the earlier of July 10, 2027, or the next Annual Meeting of Stockho", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-5174045276a5.html", "source_name": "Stock Titan", "published_at": "2026-07-14T22:12:52", "published_display": "14 Jul 2026 22:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Form 4 Sera Prognostics Inc For: 14 July By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOb05Eb3VUZmpvRFB4dmM4ZTQ3SktsMnVJMnBiUlQzV1ZRQVZXbHcwM2RERkNiMTNlTzl3eGh0cDlKaFNXTmxDRDFkRE5FRWR1ZjI4RnJBb2M4QXlPSmlieVlaaWhsc3FucVQ3anBTYVJVT2xrRUpTc3RMaUQtRE1jY3hhcW51cC16WGZReFIzYWd3ci1HQmNESm80eTVRNjIwY2c?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-14T07:00:00+00:00", "published_display": "14 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics Among 3 Intriguing Penny Stocks To Consider", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-07T17:14:36+00:00", "published_display": "07 Jul 2026 17:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Mark Christopher Capone files Form 3 for Sera Prognostics (SERA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOaGdwTURZMmVHU0JaVXh0VUtBNElTRFZvdFRqTUs0UGlyeldyWi1kMHdrOUFuWERwbm9VaGxjNlhaQTcyWUxsUkZITG0wcGdHYVFyWkN5Y2VMNy1ENHMzNEo2d2ducFZMUWRRUmRmVlFvUV9HVGxjT2l3ZUFjc1ZneVZFbkhnYTRlRWNFb3RkMU51SW05SENKZkxURXN2VkhsTmdkMDVuM2k5VmFkc2prT1AyYUJUU1gxM1J4VFFGbVFpWGV6VG1CUWZ0WQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics, Inc. Class A Actuals & Estimates (NASDAQ:SERA)", "summary": "This article provides financial actuals and estimates for Sera Prognostics, Inc. (NASDAQ:SERA), detailing its stock performance, analyst forecasts, earnings, and revenue. It covers key financial metrics, stock volatility, market capitalization, and upcoming earnings report dates.", "url": "https://www.tradingview.com/symbols/NASDAQ-SERA/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-07-01T07:08:56", "published_display": "01 Jul 2026 07:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Veteran diagnostics leader Mark Capone joins Sera Prognostics (NASDAQ: SERA) board", "summary": "Sera Prognostics (NASDAQ: SERA) has appointed veteran diagnostics leader Mark Capone to its Board of Directors as a Class II director, effective July 1, 2026. Capone, who has over 40 years of experience in the diagnostics and life sciences sectors, will also serve on the Compensa", "url": "https://www.stocktitan.net/sec-filings/SERA/8-k-sera-prognostics-inc-reports-material-event-69f3c083b498.html", "source_name": "Stock Titan", "published_at": "2026-07-01T05:39:26", "published_display": "01 Jul 2026 05:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mark Capone appointed to Sera Prognostics board, joins Compensation Committee", "summary": "Sera Prognostics has appointed Mark Capone as a Class II director, effective July 1, 2026, and he will also serve on the Compensation Committee. Capone brings over 40 years of experience as a healthcare executive, including his role as CEO of Precision Medicine Advisors and forme", "url": "https://www.tradingview.com/news/tradingview:70a2e40e184cf:0-mark-capone-appointed-to-sera-prognostics-board-joins-compensation-committee/", "source_name": "TradingView", "published_at": "2026-07-01T00:39:26", "published_display": "01 Jul 2026 00:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS", "summary": "Sera Prognostics Inc. announced Mark Capone will join its Board of Directors effective July 1, 2026. Capone brings over 40 years of leadership experience in diagnostics and life sciences, including his past role as CEO of Myriad Genetics. His expertise is expected to significantl", "url": "https://www.sahmcapital.com/news/content/sera-prognostics-announces-appointment-of-mark-capone-to-its-board-of-directors-2026-06-30", "source_name": "Sahm", "published_at": "2026-06-30T19:10:52", "published_display": "30 Jun 2026 19:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics adds former Myriad CEO Mark Capone to board", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQbE5Ra2lfNGhhOW5vMk85RU1xTzlUbHBjMmVZMDNCXzhldXZoVl9URUZ3OUJjQmxFSzVIazBjd3lWdXF3OEw3LVVKdG9NeUg4RjhCY1UtTUZNNk80NFZGdlJFT3pfdFlBdmpfVkY3SDM3cnlLU0p1Zi1lZ3U5alVtU1ZaUXJqYUE0TWx6eHhMSW5FMzh5aXV3T01mRFIyX0xyOWNEZXl3QUNKWmdSSjFQWjc4Ul9LbUZzaWpnVmpn?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics, Inc. Class A Actuals & Estimates (BOATS:SERA)", "summary": "This article provides an overview of Sera Prognostics, Inc. (SERA) stock, including financial actuals, analyst estimates, and key company data. It details the stock's highest and lowest prices, upcoming earnings reports, and recent financial performance in terms of earnings per s", "url": "https://www.tradingview.com/symbols/BOATS-SERA/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T21:10:07", "published_display": "25 Jun 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/sera-prognostics-collaborates-arpa-h-200500408.html", "source_name": "PR Newswire", "published_at": "2026-06-24T20:05:00+00:00", "published_display": "24 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "All You Need to Know About Sera Prognostics (SERA) Rating Upgrade to Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQN3RxcVNiVFZMRjZKQzZONTVsLVVCQm51UHBUZzlPMFNULXNyYkpRMUhCbEVPTS1mSTVoOE5ValVqeUZPdXA5d3prNkJWVGhtVnUxWEw5MU44aHo3dlpOQ2RLSEkzanJ6aHdCTHNickk2dlZvUVRKR0FlYTl4WVg5V3ctOXFRZEU2blRRaFlfLVRfR1lRbzVEenN0b0hkOVU?oc=5", "source_name": "Market source", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "SERA (NASDAQ: SERA) Rule 144 notice: RSUs vesting and insider sales", "summary": "SERA (NASDAQ: SERA) has filed a Rule 144 notice revealing the vesting of 6,990 Class A Common shares tied to Restricted Stock Units on June 11, 2026. The filing also reports that insider Zhenya Lindgardt disposed of 2,973 shares on March 11, 2026, and an additional 20,755 shares ", "url": "https://www.stocktitan.net/sec-filings/SERA/144-sera-prognostics-inc-sec-filing-66176a0c5e80.html", "source_name": "Stock Titan", "published_at": "2026-06-15T19:40:41", "published_display": "15 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA (NASDAQ: SERA) \u2014 Proposed sale of 2,179 Class A shares on 06/11/2026", "summary": "Sera Prognostics, Inc. (NASDAQ: SERA) has filed a Form 144 notice for the proposed sale of 2,179 Class A Common shares stemming from restricted stock unit vesting, scheduled for June 11, 2026, through Morgan Stanley Smith Barney LLC on NASDAQ. The filing also indicates a prior sa", "url": "https://www.stocktitan.net/sec-filings/SERA/144-sera-prognostics-inc-sec-filing-654618b66cf8.html", "source_name": "Stock Titan", "published_at": "2026-06-15T19:40:41", "published_display": "15 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA (NASDAQ: SERA) CMO executes 362-share tax sell-to-cover trade", "summary": "SERA Prognotics, Inc.'s Chief Medical Officer, Tiffany Eul Davis, sold 362 shares of Class A Common Stock on June 11, 2026, at a weighted average price of $2.01 per share. This transaction was a mandated \"sell to cover\" to fulfill tax withholding obligations from restricted stock", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-8fef4e79b369.html", "source_name": "Stock Titan", "published_at": "2026-06-15T19:40:41", "published_display": "15 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA (NASDAQ) Form 144: Class A Common sales tied to RSU vesting on 06/11/2026", "summary": "SERA Prognostics, Inc. filed a Form 144 indicating proposed sales of Class A Common stock linked to restricted stock unit vesting on June 11, 2026. The filing details securities to be sold and includes information on prior sales made by Austin Aerts on March 11, 2026, and June 9,", "url": "https://www.stocktitan.net/sec-filings/SERA/144-sera-prognostics-inc-sec-filing-77f0b73ac7c4.html", "source_name": "Stock Titan", "published_at": "2026-06-15T19:40:41", "published_display": "15 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA (NASDAQ: SERA) CCO sells 4,739 shares to cover RSU tax withholding", "summary": "SERA PROGNOSTICS, INC.'s Chief Commercial Officer, Dyaarl Lee Anderson Jr., sold 4,739 shares of Class A Common Stock at a weighted average price of $2.01 per share. This transaction was mandated by the company to cover tax withholding obligations from vesting restricted stock un", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-f2c8882e1f0c.html", "source_name": "Stock Titan", "published_at": "2026-06-15T19:40:41", "published_display": "15 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics (NASDAQ: SERA) CFO sells shares to cover RSU tax obligations", "summary": "Sera Prognostics (NASDAQ: SERA) CFO Austin Aerts sold 2,037 shares of Class A common stock at a weighted average price of $2.01 per share. This sale was explicitly to cover tax withholding obligations related to vesting Restricted Stock Units (RSUs) under a mandatory \"sell-to-cov", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-d8a0eaa032f7.html", "source_name": "Stock Titan", "published_at": "2026-06-15T19:40:41", "published_display": "15 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA (SERA) General Counsel sells 2,179 shares to cover RSU taxes", "summary": "SERA PROGNOSTICS, INC.'s General Counsel, Benjamin Jackson, sold 2,179 shares of Class A Common Stock for $2.01 per share to cover tax withholding obligations on vesting restricted stock units. This \"sell to cover\" transaction was mandated by the company and not a discretionary s", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-2bd5b3efd9d0.html", "source_name": "Stock Titan", "published_at": "2026-06-15T19:40:41", "published_display": "15 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA PROGNOSTICS (NASDAQ: SERA) CEO tax-related share sale disclosed", "summary": "SERA PROGNOSTICS (NASDAQ: SERA) CEO Zhenya Lindgardt sold 6,990 shares of Class A Common Stock at a weighted average price of $2.01 per share. This transaction was a \"sell to cover\" to satisfy tax withholding obligations on vested restricted stock units, not a discretionary trade", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-0173ad273dee.html", "source_name": "Stock Titan", "published_at": "2026-06-15T19:40:41", "published_display": "15 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics CEO Lindgardt sells $43,170 in company stock By Investing.com", "summary": "Zhenya Lindgardt, CEO of Sera Prognostics (NASDAQ:SERA), sold 20,755 shares of the company's Class A Common Stock for $43,170. This transaction was non-discretionary, executed to cover tax withholding obligations tied to restricted stock unit vesting. The company recently reporte", "url": "https://za.investing.com/news/insider-trading-news/sera-prognostics-ceo-lindgardt-sells-43170-in-company-stock-93CH-4322898", "source_name": "Investing.com South Africa", "published_at": "2026-06-11T11:39:43", "published_display": "11 Jun 2026 11:39", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics CEO Lindgardt sells $43,170 in company stock", "summary": "Zhenya Lindgardt, CEO of Sera Prognostics (NASDAQ:SERA), sold 20,755 shares for $43,170 to cover tax obligations related to restricted stock units. This sale, at a weighted average price of $2.08 per share, was non-discretionary and followed company policy. The company recently r", "url": "https://m.uk.investing.com/news/insider-trading-news/sera-prognostics-ceo-lindgardt-sells-43170-in-company-stock-93CH-4722668?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-10T22:09:36", "published_display": "10 Jun 2026 22:09", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] SERA PROGNOSTICS, INC. SEC Filing", "summary": "This SEC filing (Form 144) for Sera Prognostics, Inc. details the proposed sale of 5,440 Class A Common shares by an individual named Austin Aerts, acquired through Restricted Stock Unit Vesting on June 9, 2026. The shares, valued at $11,324, are to be sold through Morgan Stanley", "url": "https://www.stocktitan.net/sec-filings/SERA/144-sera-prognostics-inc-sec-filing-ae293be7f45e.html", "source_name": "Stock Titan", "published_at": "2026-06-10T20:24:44", "published_display": "10 Jun 2026 20:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] SERA PROGNOSTICS, INC. Insider Trading Activity", "summary": "SERA PROGNOSTICS, INC.'s CEO, Zhenya Lindgardt, sold 20,755 shares of Class A common stock at a weighted average price of $2.08 per share. This transaction was a \"sell to cover\" to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs), not a ", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-7318980139cc.html", "source_name": "Stock Titan", "published_at": "2026-06-10T20:09:36", "published_display": "10 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics (SERA) CFO sells shares to cover RSU tax obligations", "summary": "Sera Prognostics CFO Austin Aerts sold 5,440 shares of Class A common stock at a weighted average price of $2.08 per share. This sale was explicitly non-discretionary, mandated by a \"sell to cover\" election to satisfy tax withholding obligations from the vesting of restricted sto", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-795e019aa8cc.html", "source_name": "Stock Titan", "published_at": "2026-06-10T14:39:30", "published_display": "10 Jun 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at Sera Prognostics (SERA) sells 1,560 planned shares", "summary": "Sera Prognostics director Sandra AJ Lawrence sold 1,560 shares of Class A common stock on June 8, 2026, at a weighted average price of $2.15 per share. The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on June 10, 2025, indicating it was a routin", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-00fa0c856921.html", "source_name": "Stock Titan", "published_at": "2026-06-09T20:39:58", "published_display": "09 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics, Inc. 8-K SEC Filing June 2026 \u2013 Submission of Matters to a Vote of Security Holders", "summary": "Sera Prognostics, Inc. announced the results of its 2026 Annual Meeting of Stockholders, held on June 4, 2026. Shareholders re-elected Kim Kamdar, Ph.D. and Sandra A. J. Lawrence to the Board of Directors and ratified the appointment of Ernst & Young LLP as the company's independ", "url": "https://www.minichart.com.sg/2026/06/05/sera-prognostics-inc-8-k-sec-filing-june-2026-submission-of-matters-to-a-vote-of-security-holders/", "source_name": "Minichart", "published_at": "2026-06-05T02:39:57", "published_display": "05 Jun 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics (NASDAQ: SERA) 2026 meeting backs board and Ernst & Young", "summary": "Sera Prognostics, Inc. held its 2026 annual stockholders meeting, with 67.5% of eligible shares represented. Stockholders elected Kim Kamdar, Ph.D. and Sandra A. J. Lawrence as Class II directors, and ratified Ernst & Young LLP as the independent registered public accounting firm", "url": "https://www.stocktitan.net/sec-filings/SERA/8-k-sera-prognostics-inc-reports-material-event-fbc3602ec2c5.html", "source_name": "Stock Titan", "published_at": "2026-06-04T21:39:57", "published_display": "04 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics | 4: Statement of changes in beneficial ownership of securities-Officer Jackson Benjamin", "summary": "This document is a Statement of changes in beneficial ownership of securities for Sera Prognostics. The filing indicates that Officer Jackson Benjamin has experienced changes in their beneficial ownership. This type of filing is typically made by company insiders to report transa", "url": "https://www.moomoo.com/news/notice/307440711/sera-prognostics-4-statement-of-changes-in-beneficial-ownership-of", "source_name": "Moomoo", "published_at": "2026-06-02T08:10:30", "published_display": "02 Jun 2026 08:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/sera-prognostics-announces-board-transition-200500202.html", "source_name": "PR Newswire", "published_at": "2026-06-01T20:05:00+00:00", "published_display": "01 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Sera Prognostics (SERA) Loses 27% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNWVdDU0x2N0pKS1lHZWRjN29ibTdHZ0poak1EVFNCNkFmbTdkVmpvMkktSUw1bU1FaEx4UTJhYjZaMFhnMHFhRGZFQmozR21zWno0TGRkeWlDRHpxX0xsVTRSMlFFeEhFSk1fVm03UjAyNHRhRFhTMVlrN2drcHdmR0NPWG1kQjBkWFdrS1YyMFEzQjhaSlVTRnRKMA?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will Sera Prognostics (NASDAQ:SERA) Spend Its Cash Wisely?", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/sera-prognostics-nasdaq-sera-spend-103925437.html", "source_name": "Simply Wall St.", "published_at": "2026-05-08T10:39:25+00:00", "published_display": "08 May 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/7699ea87-b5d2-3c73-8c6d-4e8d9aaff1a8/sera-prognostics%2C-inc.-q1.html", "source_name": "Moby", "published_at": "2026-05-07T12:30:00+00:00", "published_display": "07 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOUmpEbmJLbGkwbEZ3bnZKRnZsdjlSLWJodEpNVVFGankwRTBnUmpiajlJUGFwaDhxdkFiVFpVeWR1cjI5VW9SZzVQekUzRFJ0R3RFU1VRdlR5ZWlCRzNTX0RLQklvWVRMM2VxNWkwZVFiUTBBa2xIZFZadVRUejJTYjlxM3FoMnZqRmJBdFFuWVkyZUxIbjVOc3pMWl9aMjVfWWZWT3czLTByX184WmNaaGN3bUM5SzlYaGZ1aS00ckIxV1ozOGxBdURXTXk?oc=5", "source_name": "PR Newswire", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "SERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQTTFmWlBwWXZaSlVzLTRaRVhydVVzOUJ3SWg4anp3OUJDa0hVQUF3UVVUQnNWSDB4N3VRZld0U3hiOVh4cTJuTUZEZUQ5bHVaWVVBN1c2c18zLWgwNEtkM1JZbnQ4OUNFeTRjc1BkNUNEM3I0RDlra3ZNNDhGTGRkQ2dYWHpoLUUtbFVILUZWS0dCUUJSQ2w2bXVHTjlienlpTGJMVXk3VUhuWG42TGlvLVBTcEJrT3BF?oc=5", "source_name": "PR Newswire", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "abrdn Group holds 7.21% of Sera Prognostics (SERA) stock", "summary": "abrdn Group plc and its subsidiary abrdn Inc. have reported a beneficial ownership of 7.21% in Sera Prognostics, Inc.'s Class A common stock, totaling 2,753,525 shares as of June 30, 2026. Both entities share voting and dispositive power over these shares, which are held on behal", "url": "https://www.stocktitan.net/sec-filings/SERA/schedule-13g-a-sera-prognostics-inc-amended-passive-investment-disclo-0d3c957b2049.html", "source_name": "Stock Titan", "published_at": "2026-07-15T14:44:35", "published_display": "15 Jul 2026 14:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics grants RSUs and options to director | SERA Insider Trading", "summary": "Sera Prognostics (SERA) director Joshua Phillips received equity compensation awards on July 10, 2026, as detailed in a Form 4 filing. These awards include RSUs for 2,260 and 22,426 Class A shares and stock options for 3,477 and 34,494 shares with an exercise price of $1.97. The ", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-4488bf237da4.html", "source_name": "Stock Titan", "published_at": "2026-07-15T00:12:52", "published_display": "15 Jul 2026 00:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics (SERA) awards RSUs and $1.97 stock options to director", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNdnBpTGY3Y1dmc1BxTG4yV3dCQTRzNFRNT1drTF9DaWdZdnN5aUN3Vnp5ZnhYMG94Z0JuV3B4OF9Sczl1NllWRDM0c2RqV3ZBNmltdG1FRTExcFFLYTh6LVlBQmhOSjF4XzJCbUh5cWlRTy1WSElMb3pxbDBSR204emMtSi1tTk0yRmIwUC1xOHI4SUpfTS1EbUo1R2RFS2NFZDlkYjliS0lPb0hoMldDa09DdDM?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T22:41:44+00:00", "published_display": "14 Jul 2026 22:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics (SERA) grants new RSUs and stock options", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNUXg3a09ZY3RmeTRTUklEMWZ0dGhrMW9WZnNzak05VW9pYktnUW9WZkFMV0dHR1liM2xyMDdqTDhIY2lYRDJ4Rk1OaFZYcFZacDVtV3dCMVg0cjZBdEVCQ0ZGSkp3M0E3MDFCd2EyLTlZSlhwYUN6VW5SaVIwTFBNQnc4VWpmYl85d3pWejNrRnRSTkI2QjZURHdaaTl5RHVrSWtyNXpxV0tRUEhFT1lGT3BfTkc?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T22:41:21+00:00", "published_display": "14 Jul 2026 22:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Equity grants: Sera Prognostics (SERA) awards RSUs and options", "summary": "Sera Prognostics (SERA) board director Sandra AJ Lawrence recently received equity awards including Restricted Stock Units (RSUs) and stock options. These awards were part of her compensation, with the RSUs and options vesting based on continued service and specific dates or the ", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-e8fabd3b69c8.html", "source_name": "Stock Titan", "published_at": "2026-07-14T23:12:52", "published_display": "14 Jul 2026 23:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics (SERA) director receives RSU and stock option grants", "summary": "Sera Prognostics, Inc. director Mirza Mansoor Raza received equity awards on July 10, 2026, including Restricted Stock Units (RSUs) for 1,771 and 22,426 shares of Class A common stock, and stock options for 2,725 and 34,494 shares at an exercise price of $1.97. These awards are p", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-eb90f99076fe.html", "source_name": "Stock Titan", "published_at": "2026-07-14T23:12:52", "published_display": "14 Jul 2026 23:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics (SERA) grants RSUs and stock options to director Kim Kamdar", "summary": "Sera Prognostics (SERA) Director Kim P. Kamdar received equity compensation on July 10, 2026, including Restricted Stock Units (RSUs) and stock options. Kamdar was granted 3,421 and 22,426 RSU-linked shares of Class A Common Stock, which vest on the earlier of July 10, 2027, or t", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-e049fad5d6aa.html", "source_name": "Stock Titan", "published_at": "2026-07-14T22:12:52", "published_display": "14 Jul 2026 22:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics (SERA) grants RSUs and options to director", "summary": "Sera Prognostics director Gregory C. Critchfield received new equity awards on July 10, 2026, including restricted stock units (RSUs) and stock options. The RSUs comprise 1594 and 22426 Class A shares, vesting on the earlier of July 10, 2027, or the next Annual Meeting of Stockho", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-5174045276a5.html", "source_name": "Stock Titan", "published_at": "2026-07-14T22:12:52", "published_display": "14 Jul 2026 22:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Sera Prognostics Inc For: 14 July By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOb05Eb3VUZmpvRFB4dmM4ZTQ3SktsMnVJMnBiUlQzV1ZRQVZXbHcwM2RERkNiMTNlTzl3eGh0cDlKaFNXTmxDRDFkRE5FRWR1ZjI4RnJBb2M4QXlPSmlieVlaaWhsc3FucVQ3anBTYVJVT2xrRUpTc3RMaUQtRE1jY3hhcW51cC16WGZReFIzYWd3ci1HQmNESm80eTVRNjIwY2c?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-14T07:00:00+00:00", "published_display": "14 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics Among 3 Intriguing Penny Stocks To Consider", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-07T17:14:36+00:00", "published_display": "07 Jul 2026 17:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Mark Christopher Capone files Form 3 for Sera Prognostics (SERA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOaGdwTURZMmVHU0JaVXh0VUtBNElTRFZvdFRqTUs0UGlyeldyWi1kMHdrOUFuWERwbm9VaGxjNlhaQTcyWUxsUkZITG0wcGdHYVFyWkN5Y2VMNy1ENHMzNEo2d2ducFZMUWRRUmRmVlFvUV9HVGxjT2l3ZUFjc1ZneVZFbkhnYTRlRWNFb3RkMU51SW05SENKZkxURXN2VkhsTmdkMDVuM2k5VmFkc2prT1AyYUJUU1gxM1J4VFFGbVFpWGV6VG1CUWZ0WQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics, Inc. Class A Actuals & Estimates (NASDAQ:SERA)", "summary": "This article provides financial actuals and estimates for Sera Prognostics, Inc. (NASDAQ:SERA), detailing its stock performance, analyst forecasts, earnings, and revenue. It covers key financial metrics, stock volatility, market capitalization, and upcoming earnings report dates.", "url": "https://www.tradingview.com/symbols/NASDAQ-SERA/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-07-01T07:08:56", "published_display": "01 Jul 2026 07:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Veteran diagnostics leader Mark Capone joins Sera Prognostics (NASDAQ: SERA) board", "summary": "Sera Prognostics (NASDAQ: SERA) has appointed veteran diagnostics leader Mark Capone to its Board of Directors as a Class II director, effective July 1, 2026. Capone, who has over 40 years of experience in the diagnostics and life sciences sectors, will also serve on the Compensa", "url": "https://www.stocktitan.net/sec-filings/SERA/8-k-sera-prognostics-inc-reports-material-event-69f3c083b498.html", "source_name": "Stock Titan", "published_at": "2026-07-01T05:39:26", "published_display": "01 Jul 2026 05:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mark Capone appointed to Sera Prognostics board, joins Compensation Committee", "summary": "Sera Prognostics has appointed Mark Capone as a Class II director, effective July 1, 2026, and he will also serve on the Compensation Committee. Capone brings over 40 years of experience as a healthcare executive, including his role as CEO of Precision Medicine Advisors and forme", "url": "https://www.tradingview.com/news/tradingview:70a2e40e184cf:0-mark-capone-appointed-to-sera-prognostics-board-joins-compensation-committee/", "source_name": "TradingView", "published_at": "2026-07-01T00:39:26", "published_display": "01 Jul 2026 00:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS", "summary": "Sera Prognostics Inc. announced Mark Capone will join its Board of Directors effective July 1, 2026. Capone brings over 40 years of leadership experience in diagnostics and life sciences, including his past role as CEO of Myriad Genetics. His expertise is expected to significantl", "url": "https://www.sahmcapital.com/news/content/sera-prognostics-announces-appointment-of-mark-capone-to-its-board-of-directors-2026-06-30", "source_name": "Sahm", "published_at": "2026-06-30T19:10:52", "published_display": "30 Jun 2026 19:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics adds former Myriad CEO Mark Capone to board", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQbE5Ra2lfNGhhOW5vMk85RU1xTzlUbHBjMmVZMDNCXzhldXZoVl9URUZ3OUJjQmxFSzVIazBjd3lWdXF3OEw3LVVKdG9NeUg4RjhCY1UtTUZNNk80NFZGdlJFT3pfdFlBdmpfVkY3SDM3cnlLU0p1Zi1lZ3U5alVtU1ZaUXJqYUE0TWx6eHhMSW5FMzh5aXV3T01mRFIyX0xyOWNEZXl3QUNKWmdSSjFQWjc4Ul9LbUZzaWpnVmpn?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics, Inc. Class A Actuals & Estimates (BOATS:SERA)", "summary": "This article provides an overview of Sera Prognostics, Inc. (SERA) stock, including financial actuals, analyst estimates, and key company data. It details the stock's highest and lowest prices, upcoming earnings reports, and recent financial performance in terms of earnings per s", "url": "https://www.tradingview.com/symbols/BOATS-SERA/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T21:10:07", "published_display": "25 Jun 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/sera-prognostics-collaborates-arpa-h-200500408.html", "source_name": "PR Newswire", "published_at": "2026-06-24T20:05:00+00:00", "published_display": "24 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "All You Need to Know About Sera Prognostics (SERA) Rating Upgrade to Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQN3RxcVNiVFZMRjZKQzZONTVsLVVCQm51UHBUZzlPMFNULXNyYkpRMUhCbEVPTS1mSTVoOE5ValVqeUZPdXA5d3prNkJWVGhtVnUxWEw5MU44aHo3dlpOQ2RLSEkzanJ6aHdCTHNickk2dlZvUVRKR0FlYTl4WVg5V3ctOXFRZEU2blRRaFlfLVRfR1lRbzVEenN0b0hkOVU?oc=5", "source_name": "Market source", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA (NASDAQ: SERA) Rule 144 notice: RSUs vesting and insider sales", "summary": "SERA (NASDAQ: SERA) has filed a Rule 144 notice revealing the vesting of 6,990 Class A Common shares tied to Restricted Stock Units on June 11, 2026. The filing also reports that insider Zhenya Lindgardt disposed of 2,973 shares on March 11, 2026, and an additional 20,755 shares ", "url": "https://www.stocktitan.net/sec-filings/SERA/144-sera-prognostics-inc-sec-filing-66176a0c5e80.html", "source_name": "Stock Titan", "published_at": "2026-06-15T19:40:41", "published_display": "15 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA (NASDAQ: SERA) \u2014 Proposed sale of 2,179 Class A shares on 06/11/2026", "summary": "Sera Prognostics, Inc. (NASDAQ: SERA) has filed a Form 144 notice for the proposed sale of 2,179 Class A Common shares stemming from restricted stock unit vesting, scheduled for June 11, 2026, through Morgan Stanley Smith Barney LLC on NASDAQ. The filing also indicates a prior sa", "url": "https://www.stocktitan.net/sec-filings/SERA/144-sera-prognostics-inc-sec-filing-654618b66cf8.html", "source_name": "Stock Titan", "published_at": "2026-06-15T19:40:41", "published_display": "15 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA (NASDAQ: SERA) CMO executes 362-share tax sell-to-cover trade", "summary": "SERA Prognotics, Inc.'s Chief Medical Officer, Tiffany Eul Davis, sold 362 shares of Class A Common Stock on June 11, 2026, at a weighted average price of $2.01 per share. This transaction was a mandated \"sell to cover\" to fulfill tax withholding obligations from restricted stock", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-8fef4e79b369.html", "source_name": "Stock Titan", "published_at": "2026-06-15T19:40:41", "published_display": "15 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA (NASDAQ) Form 144: Class A Common sales tied to RSU vesting on 06/11/2026", "summary": "SERA Prognostics, Inc. filed a Form 144 indicating proposed sales of Class A Common stock linked to restricted stock unit vesting on June 11, 2026. The filing details securities to be sold and includes information on prior sales made by Austin Aerts on March 11, 2026, and June 9,", "url": "https://www.stocktitan.net/sec-filings/SERA/144-sera-prognostics-inc-sec-filing-77f0b73ac7c4.html", "source_name": "Stock Titan", "published_at": "2026-06-15T19:40:41", "published_display": "15 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA (NASDAQ: SERA) CCO sells 4,739 shares to cover RSU tax withholding", "summary": "SERA PROGNOSTICS, INC.'s Chief Commercial Officer, Dyaarl Lee Anderson Jr., sold 4,739 shares of Class A Common Stock at a weighted average price of $2.01 per share. This transaction was mandated by the company to cover tax withholding obligations from vesting restricted stock un", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-f2c8882e1f0c.html", "source_name": "Stock Titan", "published_at": "2026-06-15T19:40:41", "published_display": "15 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics (NASDAQ: SERA) CFO sells shares to cover RSU tax obligations", "summary": "Sera Prognostics (NASDAQ: SERA) CFO Austin Aerts sold 2,037 shares of Class A common stock at a weighted average price of $2.01 per share. This sale was explicitly to cover tax withholding obligations related to vesting Restricted Stock Units (RSUs) under a mandatory \"sell-to-cov", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-d8a0eaa032f7.html", "source_name": "Stock Titan", "published_at": "2026-06-15T19:40:41", "published_display": "15 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA (SERA) General Counsel sells 2,179 shares to cover RSU taxes", "summary": "SERA PROGNOSTICS, INC.'s General Counsel, Benjamin Jackson, sold 2,179 shares of Class A Common Stock for $2.01 per share to cover tax withholding obligations on vesting restricted stock units. This \"sell to cover\" transaction was mandated by the company and not a discretionary s", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-2bd5b3efd9d0.html", "source_name": "Stock Titan", "published_at": "2026-06-15T19:40:41", "published_display": "15 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA PROGNOSTICS (NASDAQ: SERA) CEO tax-related share sale disclosed", "summary": "SERA PROGNOSTICS (NASDAQ: SERA) CEO Zhenya Lindgardt sold 6,990 shares of Class A Common Stock at a weighted average price of $2.01 per share. This transaction was a \"sell to cover\" to satisfy tax withholding obligations on vested restricted stock units, not a discretionary trade", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-0173ad273dee.html", "source_name": "Stock Titan", "published_at": "2026-06-15T19:40:41", "published_display": "15 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics CEO Lindgardt sells $43,170 in company stock By Investing.com", "summary": "Zhenya Lindgardt, CEO of Sera Prognostics (NASDAQ:SERA), sold 20,755 shares of the company's Class A Common Stock for $43,170. This transaction was non-discretionary, executed to cover tax withholding obligations tied to restricted stock unit vesting. The company recently reporte", "url": "https://za.investing.com/news/insider-trading-news/sera-prognostics-ceo-lindgardt-sells-43170-in-company-stock-93CH-4322898", "source_name": "Investing.com South Africa", "published_at": "2026-06-11T11:39:43", "published_display": "11 Jun 2026 11:39", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics CEO Lindgardt sells $43,170 in company stock", "summary": "Zhenya Lindgardt, CEO of Sera Prognostics (NASDAQ:SERA), sold 20,755 shares for $43,170 to cover tax obligations related to restricted stock units. This sale, at a weighted average price of $2.08 per share, was non-discretionary and followed company policy. The company recently r", "url": "https://m.uk.investing.com/news/insider-trading-news/sera-prognostics-ceo-lindgardt-sells-43170-in-company-stock-93CH-4722668?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-10T22:09:36", "published_display": "10 Jun 2026 22:09", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] SERA PROGNOSTICS, INC. SEC Filing", "summary": "This SEC filing (Form 144) for Sera Prognostics, Inc. details the proposed sale of 5,440 Class A Common shares by an individual named Austin Aerts, acquired through Restricted Stock Unit Vesting on June 9, 2026. The shares, valued at $11,324, are to be sold through Morgan Stanley", "url": "https://www.stocktitan.net/sec-filings/SERA/144-sera-prognostics-inc-sec-filing-ae293be7f45e.html", "source_name": "Stock Titan", "published_at": "2026-06-10T20:24:44", "published_display": "10 Jun 2026 20:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] SERA PROGNOSTICS, INC. Insider Trading Activity", "summary": "SERA PROGNOSTICS, INC.'s CEO, Zhenya Lindgardt, sold 20,755 shares of Class A common stock at a weighted average price of $2.08 per share. This transaction was a \"sell to cover\" to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs), not a ", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-7318980139cc.html", "source_name": "Stock Titan", "published_at": "2026-06-10T20:09:36", "published_display": "10 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics (SERA) CFO sells shares to cover RSU tax obligations", "summary": "Sera Prognostics CFO Austin Aerts sold 5,440 shares of Class A common stock at a weighted average price of $2.08 per share. This sale was explicitly non-discretionary, mandated by a \"sell to cover\" election to satisfy tax withholding obligations from the vesting of restricted sto", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-795e019aa8cc.html", "source_name": "Stock Titan", "published_at": "2026-06-10T14:39:30", "published_display": "10 Jun 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at Sera Prognostics (SERA) sells 1,560 planned shares", "summary": "Sera Prognostics director Sandra AJ Lawrence sold 1,560 shares of Class A common stock on June 8, 2026, at a weighted average price of $2.15 per share. The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on June 10, 2025, indicating it was a routin", "url": "https://www.stocktitan.net/sec-filings/SERA/form-4-sera-prognostics-inc-insider-trading-activity-00fa0c856921.html", "source_name": "Stock Titan", "published_at": "2026-06-09T20:39:58", "published_display": "09 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics, Inc. 8-K SEC Filing June 2026 \u2013 Submission of Matters to a Vote of Security Holders", "summary": "Sera Prognostics, Inc. announced the results of its 2026 Annual Meeting of Stockholders, held on June 4, 2026. Shareholders re-elected Kim Kamdar, Ph.D. and Sandra A. J. Lawrence to the Board of Directors and ratified the appointment of Ernst & Young LLP as the company's independ", "url": "https://www.minichart.com.sg/2026/06/05/sera-prognostics-inc-8-k-sec-filing-june-2026-submission-of-matters-to-a-vote-of-security-holders/", "source_name": "Minichart", "published_at": "2026-06-05T02:39:57", "published_display": "05 Jun 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics (NASDAQ: SERA) 2026 meeting backs board and Ernst & Young", "summary": "Sera Prognostics, Inc. held its 2026 annual stockholders meeting, with 67.5% of eligible shares represented. Stockholders elected Kim Kamdar, Ph.D. and Sandra A. J. Lawrence as Class II directors, and ratified Ernst & Young LLP as the independent registered public accounting firm", "url": "https://www.stocktitan.net/sec-filings/SERA/8-k-sera-prognostics-inc-reports-material-event-fbc3602ec2c5.html", "source_name": "Stock Titan", "published_at": "2026-06-04T21:39:57", "published_display": "04 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics | 4: Statement of changes in beneficial ownership of securities-Officer Jackson Benjamin", "summary": "This document is a Statement of changes in beneficial ownership of securities for Sera Prognostics. The filing indicates that Officer Jackson Benjamin has experienced changes in their beneficial ownership. This type of filing is typically made by company insiders to report transa", "url": "https://www.moomoo.com/news/notice/307440711/sera-prognostics-4-statement-of-changes-in-beneficial-ownership-of", "source_name": "Moomoo", "published_at": "2026-06-02T08:10:30", "published_display": "02 Jun 2026 08:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/sera-prognostics-announces-board-transition-200500202.html", "source_name": "PR Newswire", "published_at": "2026-06-01T20:05:00+00:00", "published_display": "01 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics (SERA) Loses 27% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNWVdDU0x2N0pKS1lHZWRjN29ibTdHZ0poak1EVFNCNkFmbTdkVmpvMkktSUw1bU1FaEx4UTJhYjZaMFhnMHFhRGZFQmozR21zWno0TGRkeWlDRHpxX0xsVTRSMlFFeEhFSk1fVm03UjAyNHRhRFhTMVlrN2drcHdmR0NPWG1kQjBkWFdrS1YyMFEzQjhaSlVTRnRKMA?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will Sera Prognostics (NASDAQ:SERA) Spend Its Cash Wisely?", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/sera-prognostics-nasdaq-sera-spend-103925437.html", "source_name": "Simply Wall St.", "published_at": "2026-05-08T10:39:25+00:00", "published_display": "08 May 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sera Prognostics, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/7699ea87-b5d2-3c73-8c6d-4e8d9aaff1a8/sera-prognostics%2C-inc.-q1.html", "source_name": "Moby", "published_at": "2026-05-07T12:30:00+00:00", "published_display": "07 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOUmpEbmJLbGkwbEZ3bnZKRnZsdjlSLWJodEpNVVFGankwRTBnUmpiajlJUGFwaDhxdkFiVFpVeWR1cjI5VW9SZzVQekUzRFJ0R3RFU1VRdlR5ZWlCRzNTX0RLQklvWVRMM2VxNWkwZVFiUTBBa2xIZFZadVRUejJTYjlxM3FoMnZqRmJBdFFuWVkyZUxIbjVOc3pMWl9aMjVfWWZWT3czLTByX184WmNaaGN3bUM5SzlYaGZ1aS00ckIxV1ozOGxBdURXTXk?oc=5", "source_name": "PR Newswire", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQTTFmWlBwWXZaSlVzLTRaRVhydVVzOUJ3SWg4anp3OUJDa0hVQUF3UVVUQnNWSDB4N3VRZld0U3hiOVh4cTJuTUZEZUQ5bHVaWVVBN1c2c18zLWgwNEtkM1JZbnQ4OUNFeTRjc1BkNUNEM3I0RDlra3ZNNDhGTGRkQ2dYWHpoLUUtbFVILUZWS0dCUUJSQ2w2bXVHTjlienlpTGJMVXk3VUhuWG42TGlvLVBTcEJrT3BF?oc=5", "source_name": "PR Newswire", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 87, "total_relevant": 54, "sentiment_summary": {"positive": 4, "negative": 2, "neutral": 48, "score": 51, "total": 54, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 18.7, "count": 34}, {"event": "earnings", "label": "Earnings", "weight": 8.25, "count": 18}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 1.97, "latest_week": "2026-07-10", "one_week_move": -1.5, "four_week_move": 5.3, "twelve_week_move": -14.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.199129, "market_dynamics_buy_signal": false, "relative_strength": -37.027062, "fair_value_gap": -57.2, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 47.4262, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.5% over one week, +5.3% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 60, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 24}, {"label": "Market source", "count": 12}, {"label": "PR Newswire", "count": 4}, {"label": "TradingView", "count": 3}, {"label": "StockStory", "count": 2}, {"label": "Investing.com Nigeria", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "Sahm", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 42}, {"label": "Industry context", "count": 12}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 34}, {"label": "Earnings", "count": 18}, {"label": "Analyst action", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "42", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.5% over one week, +5.3% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "abrdn Group holds 7.21% of Sera Prognostics (SERA) stock"}], "updated_at": "2026-07-16T03:30:12.875927+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}